The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
Sign up to receive updates about the conference: click here.
The first European Congress of Biotechnology in Interlaken, Switzerland, in 1978 marked the inauguration of the European Federation of Biotechnology (EFB). In 2018, we are delighted to welcome you back to Switzerland to celebrate the 40th anniversary of the longest running biotechnology congress in Europe. Between Lake Geneva and surrounding mountains, ECB2018 will be held in the beautiful and vibrant city of Geneva.
EFB began as a rather small group of working parties from different European countries. Their interests ranged from fermentation technology to the public perception of biotechnology, applied microbiology and genetics, downstream processing and measurement and control. Forty years later, EFB is now open to all who share our mission of promoting the safe, sustainable and ethical use of biological systems for the benefit of mankind. The current 30,000 personal members, who span the world from Latin America to China, Korea and Japan, is also a reflection of the success of recent EFB congresses.
It brings together farmers and other stakeholders from Asia to learn about plant biotechnology through first-hand experience by visiting plant biotech commercial farms and R&D biotech facilities; and interacting with farmers, scientists, media and policymakers.
The FX Program has been held annually since 2007. The 9th FX Program was held Mar 2-7 in the Philippines. The CropLife Asia, CropLife Philippines and the Biotechnology Coalition of the Philippines have organized the nine editions of the FX program.